Literature DB >> 23846025

Case study: two fatal case reports of acute yohimbine intoxication.

Colin Anderson1, Dan Anderson, Nicole Harre, Norman Wade.   

Abstract

Yohimbine is an alkaloid that has been encountered on the streets as an aphrodisiac, hallucinogen, dietary supplement and erectile dysfunction drug. Yohimbine hydrochloride is an alpha 2-adrenoreceptor antagonist, blocking the pre- and postsynaptic alpha-2 adrenoreceptors and causing an increased release of noradrenaline and dopamine. An average oral dose of 5-15 mg produces a therapeutic whole blood level range of 40-400 ng/mL. Overdoses leading to neurotoxic effects have been seen with blood concentrations up to 5,000 ng/mL. The laboratories from the Maricopa County Medical Examiner and the Los Angeles County Department of Coroner each encountered a case in which yohimbine was identified in whole blood by means of a liquid-liquid basic drug extraction with detection on a GC-MS. Because validated quantitative methods for yohimbine did not exist at either facility, both agencies referred the blood specimens to NMS Labs, Inc. The reference laboratory analyzed the blood specimens with an LC-MS-MS and determined the quantitative values of yohimbine to be 7,400 and 5,400 ng/mL. Given the absence of other significant positive findings and the substantial yohimbine blood concentrations cited, the respective Medical Examiners determined the cause of death to be acute yohimbine intoxication with the mode being an accident. Yohimbine is a rarely encountered drug in medical examiner casework, and interpretation of the results is difficult to assess toward the cause and manner of death without such case studies being described.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23846025     DOI: 10.1093/jat/bkt057

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  5 in total

1.  Reverse takotsubo cardiomyopathy with use of male enhancers.

Authors:  Carlos E Rodriguez-Castro; Fatima Saifuddin; Mateo Porres-Aguilar; Sarmad Said; David Gough; Tariq Siddiqui; Debabrata Mukherjee; Aamer Abbas
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-01

2.  Bulk muscles, loose cables.

Authors:  Chamari R D G Liyanage; Venkata Kodali
Journal:  BMJ Case Rep       Date:  2014-10-17

3.  Comparison of TWA and PEP as indices of α2- and ß-adrenergic activation.

Authors:  L Drost; J B Finke; J Port; H Schächinger
Journal:  Psychopharmacology (Berl)       Date:  2022-04-08       Impact factor: 4.530

4.  CYP2D6 phenotype explains reported yohimbine concentrations in four severe acute intoxications.

Authors:  Anna Mueller-Schoell; Robin Michelet; Ferdinand Weinelt; Charlotte Kloft; Gerd Mikus
Journal:  Arch Toxicol       Date:  2021-05-24       Impact factor: 5.153

5.  Effects of Acute Yohimbine Hydrochloride Supplementation on Repeated Supramaximal Sprint Performance.

Authors:  Megan E Barnes; Camryn R Cowan; Lauren E Boag; Julianne G Hill; Morgan L Jones; Kylie M Nixon; Mckenzie G Parker; Shelby K Parker; Mary V Raymond; Lillie H Sternenberg; Shelby L Tidwell; Taylor M Yount; Tyler D Williams; Rebecca R Rogers; Christopher G Ballmann
Journal:  Int J Environ Res Public Health       Date:  2022-01-25       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.